nodes	percent_of_prediction	percent_of_DWPC	metapath
Tripelennamine—HRH1—Histamine receptors—HRH3—narcolepsy	0.264	0.28	CbGpPWpGaD
Tripelennamine—HRH1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0411	0.0436	CbGpPWpGaD
Tripelennamine—HRH1—Monoamine GPCRs—HTR2A—narcolepsy	0.0244	0.0258	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0224	0.0237	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0224	0.0237	CbGpPWpGaD
Tripelennamine—Cyclobenzaprine—HTR2A—narcolepsy	0.0221	0.387	CrCbGaD
Tripelennamine—HRH1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0216	0.0229	CbGpPWpGaD
Tripelennamine—HRH1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0205	0.0217	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.02	0.0212	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.02	0.0212	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0193	0.0205	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—HCRT—narcolepsy	0.0184	0.0195	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0173	0.0183	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0173	0.0183	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0167	0.0177	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0164	0.0174	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0148	0.0157	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0148	0.0157	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0143	0.0152	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—TRH—narcolepsy	0.0139	0.0148	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0124	0.0132	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0122	0.0129	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HCRTR1—narcolepsy	0.0113	0.012	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HCRTR2—narcolepsy	0.0113	0.012	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—P2RY11—narcolepsy	0.0109	0.0115	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0108	0.0115	CbGpPWpGaD
Tripelennamine—Doxepin—HTR2A—narcolepsy	0.0102	0.178	CrCbGaD
Tripelennamine—HRH1—G alpha (q) signalling events—TAC1—narcolepsy	0.0101	0.0107	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—NPS—narcolepsy	0.0101	0.0107	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00943	0.01	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HCRT—narcolepsy	0.00926	0.00982	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00921	0.00977	CbGpPWpGaD
Tripelennamine—Promazine—HTR2A—narcolepsy	0.00905	0.158	CrCbGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00904	0.00959	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00904	0.00959	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—PENK—narcolepsy	0.00825	0.00875	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00808	0.00857	CbGpPWpGaD
Tripelennamine—Imipramine—HTR2A—narcolepsy	0.00792	0.139	CrCbGaD
Tripelennamine—Amitriptyline—HTR2A—narcolepsy	0.00787	0.138	CrCbGaD
Tripelennamine—HRH1—GPCR ligand binding—TRH—narcolepsy	0.00702	0.00744	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0067	0.0071	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0067	0.0071	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00637	0.00676	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00637	0.00676	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—P2RY11—narcolepsy	0.00615	0.00653	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HRH3—narcolepsy	0.00615	0.00653	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00608	0.00645	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HCRTR2—narcolepsy	0.00579	0.00614	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HCRTR1—narcolepsy	0.00579	0.00614	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—P2RY11—narcolepsy	0.00559	0.00593	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00544	0.00577	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HCRT—narcolepsy	0.00523	0.00555	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—TAC1—narcolepsy	0.0051	0.00541	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—NPS—narcolepsy	0.0051	0.00541	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HCRT—narcolepsy	0.00475	0.00504	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0047	0.00499	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PENK—narcolepsy	0.00466	0.00495	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PENK—narcolepsy	0.00423	0.00449	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00403	0.00427	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—TRH—narcolepsy	0.00397	0.00421	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—TRH—narcolepsy	0.0036	0.00382	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HRH3—narcolepsy	0.00348	0.00369	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HCRTR1—narcolepsy	0.00342	0.00363	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HCRTR2—narcolepsy	0.00342	0.00363	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—P2RY11—narcolepsy	0.0033	0.0035	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HRH3—narcolepsy	0.00316	0.00335	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR2A—narcolepsy	0.00307	0.00325	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—NPS—narcolepsy	0.00288	0.00306	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—TAC1—narcolepsy	0.00288	0.00306	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HCRT—narcolepsy	0.00281	0.00298	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CHKB—narcolepsy	0.00276	0.00293	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—TAC1—narcolepsy	0.00262	0.00277	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—NPS—narcolepsy	0.00262	0.00277	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PENK—narcolepsy	0.0025	0.00265	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TRH—narcolepsy	0.00213	0.00226	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CPT1B—narcolepsy	0.00188	0.00199	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HRH3—narcolepsy	0.00187	0.00198	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR2A—narcolepsy	0.00173	0.00184	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR2A—narcolepsy	0.00157	0.00167	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TAC1—narcolepsy	0.00155	0.00164	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NPS—narcolepsy	0.00155	0.00164	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR2A—narcolepsy	0.00093	0.000986	CbGpPWpGaD
